300247 融捷健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.7812.65113.8772.952-7.800
总资产报酬率 ROA (%)2.3132.20311.4082.438-6.287
投入资产回报率 ROIC (%)2.6402.48012.8412.761-7.404

边际利润分析
销售毛利率 (%)31.99832.86024.01724.16126.255
营业利润率 (%)16.04511.22429.6057.273-9.312
息税前利润/营业总收入 (%)13.6389.80027.4587.463-6.841
净利润/营业总收入 (%)12.0547.91728.7775.973-10.754

收益指标分析
经营活动净收益/利润总额(%)86.86381.011-0.14428.47123.288
价值变动净收益/利润总额(%)12.41628.914100.09861.205106.624
营业外收支净额/利润总额(%)-0.1250.561-0.566-1.393-5.068

偿债能力分析
流动比率 (X)6.8116.5766.1283.9234.129
速动比率 (X)5.6855.4194.6372.7563.153
资产负债率 (%)11.54512.18513.71516.3080.131
带息债务/全部投入资本 (%)2.9483.2833.7353.9113.489
股东权益/带息债务 (%)3,236.9812,876.9502,481.2982,344.2182,737.898
股东权益/负债合计 (%)719.759683.126604.796495.522645.244
利息保障倍数 (X)-5.713-6.591-13.86625.770-3.383

营运能力分析
应收账款周转天数 (天)23.54027.44928.44226.77158.176
存货周转天数 (天)114.138167.352171.663118.705136.207